Federica Cavallo Selected Research

Federica Cavallo Research Topics

Disease

117	Neoplasms (Cancer) 01/2022 - 02/2002
33	Multiple Myeloma 09/2020 - 01/2004
32	Breast Neoplasms (Breast Cancer) 01/2022 - 06/2004
27	Carcinoma (Carcinomatosis) 01/2022 - 03/2004
16	Carcinogenesis 01/2022 - 02/2002
12	Neoplasm Metastasis (Metastasis) 06/2020 - 02/2010
10	Melanoma (Melanoma, Malignant) 01/2022 - 11/2011
9	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2022 - 12/2018
7	Disease Progression 01/2022 - 09/2006
6	Infections 02/2022 - 09/2013
5	Lymphoma (Lymphomas) 07/2021 - 04/2003
5	Inflammation (Inflammations) 12/2020 - 06/2005
4	Residual Neoplasm 01/2018 - 04/2003
4	Hyperplasia 01/2016 - 03/2004
3	Hematologic Neoplasms (Hematological Malignancy) 02/2022 - 06/2005
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 04/2003
3	Paraproteinemias (Monoclonal Gammopathy) 04/2021 - 09/2006
3	Necrosis 02/2018 - 01/2007
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 03/2021
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 04/2021 - 01/2018
2	Monoclonal Gammopathy of Undetermined Significance 04/2021 - 01/2018
2	Triple Negative Breast Neoplasms 02/2021 - 06/2020
2	Thrombocytopenia (Thrombopenia) 12/2018 - 09/2012
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2015 - 01/2014
2	Communicable Diseases (Infectious Diseases) 06/2015 - 05/2015
2	Neutropenia 09/2014 - 09/2012
2	Lung Neoplasms (Lung Cancer) 01/2014 - 06/2013
2	Adenocarcinoma 05/2013 - 02/2010
2	Renal Cell Carcinoma (Grawitz Tumor) 09/2012 - 11/2008

Drug/Important Bio-Agent (IBA)

40	VaccinesIBA 01/2022 - 03/2004
31	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2004
24	AntigensIBA 01/2022 - 06/2004
22	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2004
15	AntibodiesIBA 01/2020 - 02/2002
14	DNA VaccinesIBA 01/2022 - 04/2004
14	Thalidomide (Thalomid)FDA Link 03/2015 - 01/2004
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2006
10	Lenalidomide (CC 5013)FDA Link 01/2021 - 06/2008
10	Bortezomib (Velcade)FDA Link 03/2015 - 03/2006
9	CytokinesIBA 01/2021 - 06/2004
9	Melphalan (Alkeran)FDA LinkGeneric 09/2020 - 04/2006
9	Biological ProductsIBA 07/2020 - 07/2006
8	Prednisone (Sone)FDA LinkGeneric 01/2021 - 04/2006
8	Cancer VaccinesIBA 11/2018 - 01/2009
6	selinexorIBA 02/2022 - 07/2020
6	A-Form DNA (A-DNA)IBA 07/2015 - 06/2006
6	Interleukin-12 (IL 12)IBA 06/2006 - 02/2002
5	Rituximab (Mabthera)FDA Link 02/2022 - 01/2021
5	Pharmaceutical PreparationsIBA 03/2021 - 04/2008
5	Glutamic Acid (Glutamate)FDA Link 01/2021 - 01/2016
5	Cystine (L-Cystine)IBA 01/2021 - 01/2016
5	AntiportersIBA 01/2021 - 01/2016
5	AutoantigensIBA 01/2020 - 09/2008
5	Dexamethasone (Maxidex)FDA LinkGeneric 08/2013 - 01/2004
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 12/2008
4	Complement System Proteins (Complement)IBA 09/2020 - 05/2013
4	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2020 - 04/2010
4	EpitopesIBA 01/2020 - 01/2009
4	Immunomodulating AgentsIBA 03/2015 - 03/2005
4	Monoclonal AntibodiesIBA 12/2014 - 09/2008
3	Immunoglobulin G (IgG)IBA 01/2022 - 05/2013
3	Toll-Like Receptor 2IBA 01/2022 - 12/2013
3	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 09/2020 - 02/2010
3	Proteoglycans (Proteoglycan)IBA 11/2019 - 01/2017
3	AngiomotinsIBA 01/2016 - 06/2006
3	Proteasome InhibitorsIBA 03/2015 - 01/2012
3	InterleukinsIBA 06/2014 - 06/2004
2	chondroitin sulfate proteoglycan 4IBA 01/2022 - 11/2011
2	HMGB1 Protein (HMG1)IBA 01/2022 - 12/2013
2	Immunoglobulin M (IgM)IBA 04/2021 - 01/2018
2	Small Interfering RNA (siRNA)IBA 09/2020 - 02/2010
2	Complement C3 (C3 Complement)IBA 09/2020 - 09/2013
2	RNA (Ribonucleic Acid)IBA 09/2020 - 01/2014
2	MicroRNAs (MicroRNA)IBA 01/2020 - 06/2013
2	Chondroitin Sulfate ProteoglycansIBA 01/2019 - 11/2011
2	SuspensionsIBA 12/2018 - 12/2015
2	PanobinostatIBA 12/2018 - 09/2012
2	Oxygen (Dioxygen)IBA 02/2018 - 01/2015
2	GTP Phosphohydrolases (GTPases)IBA 01/2018 - 01/2017
2	Transcription Factors (Transcription Factor)IBA 11/2017 - 03/2010
2	human ERBB2 proteinIBA 01/2017 - 01/2014
2	Chondroitin Sulfates (Chondroitin Sulfate)IBA 01/2017 - 11/2011
2	ErbB Receptors (EGF Receptor)IBA 03/2016 - 06/2006
2	PerforinIBA 06/2014 - 06/2014
2	Trastuzumab (Herceptin)FDA Link 05/2014 - 01/2013
2	ErbB-2 ReceptorIBA 05/2014 - 06/2006
2	Stem Cell FactorIBA 01/2014 - 01/2014
2	LigandsIBA 12/2013 - 01/2007
2	EnzymesIBA 05/2013 - 06/2005
2	Interleukin-15 (Interleukin 15)IBA 09/2012 - 06/2004
2	Neoplasm Antigens (Tumor Antigens)IBA 12/2011 - 11/2008
2	Phosphotransferases (Kinase)IBA 11/2011 - 10/2010
2	Mevalonic Acid (Mevalonate)IBA 11/2011 - 12/2010

Therapy/Procedure

52	Therapeutics 01/2022 - 06/2004
34	Immunotherapy 01/2022 - 03/2004
11	Drug Therapy (Chemotherapy) 02/2022 - 04/2003
10	Stem Cell Transplantation 01/2021 - 03/2006
3	Injections 06/2013 - 05/2008
2	Transplantation 01/2022 - 06/2014
2	Radiotherapy 01/2022 - 01/2021